In some studies, the overexpression of Gpnmb improved hepatic steatosis and fibrosis in a diet-induced obesity model, and that Gpnmb interacts with calnexin in liver macrophages, leading to a reduction in oxidative stress [33,34]. Here, CANX is linked to obesity disorder.